![Michael G. Moore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael G. Moore
Presidente presso
Chronos Therapeutics Ltd.
Profilo
Michael G.
Moore is currently the Non-Executive Vice Chairman at MISSION Therapeutics Ltd., Chairman at Chronos Therapeutics Ltd., Non-Executive Chairman at Macrophage Pharma Ltd., and Non-Executive Director at Mironid Ltd. Previously, he served as the Chief Executive Officer & Director at Piramed Ltd. from 2003 to 2008.
He also held positions as Chairman at Oxford BioTherapeutics Ltd., Trillium Therapeutics, Inc., Asterion Ltd., Akinion Pharmaceuticals AB, and Akamis Bio Ltd. Additionally, he was the Chairman at Phogen Ltd. from 2001 to 2003 and Chief Scientific Officer & Research Director at Xenova Group Plc from 1988 to 2003.
He served as a Director at Aptose Biosciences, Inc. and as an Independent Director at Trillium Therapeutics ULC from 2013 to 2020.
Furthermore, he was a Non-Executive Director at BliNK Therapeutics Ltd. Dr. Moore holds a doctorate degree from The University of Nottingham.
Posizioni attive di Michael G. Moore
| Società | Posizione | Inizio |
|---|---|---|
MISSION Therapeutics Ltd.
 MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs targeting enzymes involved in cancer and other diseases | Direttore/Membro del Consiglio | 01/01/2017 |
Chronos Therapeutics Ltd.
 Chronos Therapeutics Ltd. BiotechnologyHealth Technology Develops therapies in degenerative and behavioral brain diseases | Presidente | - |
Mironid Ltd.
 Mironid Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary drug candidate molecules | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Michael G. Moore
| Società | Posizione | Fine |
|---|---|---|
| TRILLIUM THERAPEUTICS | Direttore/Membro del Consiglio | 30/06/2020 |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Presidente | 01/01/2017 |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody-based medicines for oncology | Presidente | 26/06/2013 |
Trillium Therapeutics, Inc. /Old/
 Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Presidente | 01/01/2013 |
Piramed Ltd.
 Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services Develops drugs, diagnostics, and other therapeutic products | Amministratore Delegato | 01/01/2008 |
Formazione di Michael G. Moore
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
43
Relazioni di 1° grado
16
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 16 |
|---|---|
Xenova Group Plc
 Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Aptose Biosciences, Inc.
 Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services Develops drugs, diagnostics, and other therapeutic products | Commercial Services |
Trillium Therapeutics, Inc.
 Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody-based medicines for oncology | Health Technology |
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Commercial Services |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Asterion Ltd.
 Asterion Ltd. BiotechnologyHealth Technology Develops novel therapeutic products | Health Technology |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical for the treatment of acute myeloid leukemia | Health Technology |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Health Technology |
Phogen Ltd. | |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs targeting enzymes involved in cancer and other diseases | Health Technology |
BliNK Therapeutics Ltd.
 BliNK Therapeutics Ltd. BiotechnologyHealth Technology Produces therapeutic monoclonal antibodies | Health Technology |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Develops therapies in degenerative and behavioral brain diseases | Health Technology |
Mironid Ltd.
Mironid Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary drug candidate molecules | Health Technology |
Macrophage Pharma Ltd.
 Macrophage Pharma Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
